by GlobeNewsWire | Jul 19, 2016 | Globe Newswire
San Francisco, July 19, 2016 (GLOBE NEWSWIRE) — The global IVD quality control market is expected to reach over USD 1.13 billion by 2024 according to a new report by Grand View Research, Inc. The continually evolving technology-oriented changes in the...
by GlobeNewsWire | Jul 19, 2016 | Globe Newswire
San Francisco, July 19, 2016 (GLOBE NEWSWIRE) — The global newborn screening market is expected to reach USD 1.43 billion by 2022, according to a new report by Grand View Research Inc. Increasing occurrence of congenital disorders that lead to mental retardation...
by GlobeNewsWire | Jul 18, 2016 | Globe Newswire
–EMA Issued a Positive Opinion for Orphan Drug Designation for AEB1102– –Initiated Two Phase 1 Clinical Trials of AEB1102 for Treatment of Hyperargininaemia and Hematological Malignancies– AUSTIN, Texas, July 18, 2016 (GLOBE NEWSWIRE) —...
by GlobeNewsWire | Jul 18, 2016 | Globe Newswire
PRINCETON, N.J., July 18, 2016 (GLOBE NEWSWIRE) — Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that its lead Lm immunotherapy candidate, axalimogene filolisbac (AXAL), has been classified...
by GlobeNewsWire | Jul 15, 2016 | Globe Newswire
NORTHVALE, N.J., July 15, 2016 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP) today announced that the U.S. Food and Drug Administration (the “FDA”) has issued a Complete Response Letter (the “CRL”)...